semaglutide/bpc 157 acetate BPC-157 | CAS#216441-37-1 Semaglutide | GLP-1 Receptor Agonist

Structured programs incorporating reduced-calorie diets (typically 500-750 kcal/day deficit), increased physical activity (150 minutes of moderate-intensity exercise weekly for weight loss

The peptide does not stimulate the tissue growth pathways that cause joint and tendon issues

Eat protein at every meal

calcium/phosporus/magnesium exchange disorders (rickets, osteopathy, halisteresis, pregnancy, etc)

PR Newswire (2025) 12

(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)